Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q4 FY 24 Earnings Conference Call17-05-2024
17-05-2024
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording of the Earnings Conference Call for Q4 FY 24/ FY 2415-05-2024
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Audited Financial Results for the Quarter and Year ended March 31, 202415-05-2024
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation
Q4 FY 24 /FY 24 Investor Presentation15-05-2024
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Smt. Nehal Garewal as Non-Executive Non-Independent Director of the Company13-05-2024
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Shri Pradeep Thakur as Non-Executive Independent Director of the Company13-05-2024
Aarti Pharmalabs Ltd - 543748 - Corporate Action-Board approves Dividend
The Board approved Final Dividend @ 20% i.e. Re. 1/- per equity share of face value Rs. 5/- each for the FY ended March 31, 2024, subject to Shareholders'' approval at ensuing AGM.13-05-2024
Aarti Pharmalabs Ltd - 543748 - Results- Financials For The Year Ended March 31, 2024
Audited Financial Results for the quarter and year ended March 31, 2024.13-05-2024
Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting13-05-2024